Source: Journal of clinical endocrinology & metabolism. Unidade: FM
Subjects: PEROXIDASE, AUTOANTICORPOS, FATORES DE RISCO, EPIDEMIOLOGIA
ABNT
MENEGHINI, Vandrize et al. Potential seterminants of thyroid peroxidase antibodies and mortality risk: results from the ELSA-Brasil Study. Journal of clinical endocrinology & metabolism, v. 109, n. 2, p. e698-e710, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76810. Acesso em: 21 maio 2025.APA
Meneghini, V., Tebar, W. R., Santos, I. de S., Janovsky, C. C. P. S., Almeida-Pititto, B. de, Birck, M. G., et al. (2024). Potential seterminants of thyroid peroxidase antibodies and mortality risk: results from the ELSA-Brasil Study. Journal of clinical endocrinology & metabolism, 109( 2), e698-e710. doi:10.1210/clinem/dgad539NLM
Meneghini V, Tebar WR, Santos I de S, Janovsky CCPS, Almeida-Pititto B de, Birck MG, Lotufo PA, Goulart AC, Sgarbi JA, Benseñor IJM. Potential seterminants of thyroid peroxidase antibodies and mortality risk: results from the ELSA-Brasil Study [Internet]. Journal of clinical endocrinology & metabolism. 2024 ; 109( 2): e698-e710.[citado 2025 maio 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76810Vancouver
Meneghini V, Tebar WR, Santos I de S, Janovsky CCPS, Almeida-Pititto B de, Birck MG, Lotufo PA, Goulart AC, Sgarbi JA, Benseñor IJM. Potential seterminants of thyroid peroxidase antibodies and mortality risk: results from the ELSA-Brasil Study [Internet]. Journal of clinical endocrinology & metabolism. 2024 ; 109( 2): e698-e710.[citado 2025 maio 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76810